Ayuk SM, Abrahamse H, Houreld NN (2016) The role of photobiomodulation on gene expression of cell adhesion molecules in diabetic wounded fibroblasts in vitro. J Photochem Photobiol B 161:368–374. https://doi.org/10.1016/j.jphotobiol.2016.05.027

Article  CAS  PubMed  Google Scholar 

Dasari S, Tchounwou PB (2014) Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 740:364–378. https://doi.org/10.1016/j.ejphar.2014.07.025

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dohopolski M, Gottumukkala S, Gomez D, Iyengar P (2021) Radiation therapy in non-small-cell lung cancer. Cold Spring Harb Perspect Med 11. https://doi.org/10.1101/cshperspect.a037713

Fan XX, Wu Q (2022) Decoding lung cancer at single-cell level. Front Immunol 13:883758. https://doi.org/10.3389/fimmu.2022.883758

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fouad S, Hauton D, D’Angiolella V (2020) E2F1: cause and consequence of dna replication stress. Front Mol Biosci 7:599332. https://doi.org/10.3389/fmolb.2020.599332

Article  CAS  PubMed  Google Scholar 

Ge P, Cao L, Zheng M, Yao Y, Wang W, Chen X (2021) LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis. Exp Mol Pathol 120:104633. https://doi.org/10.1016/j.yexmp.2021.104633

Article  CAS  PubMed  Google Scholar 

Ghosh S (2019) Cisplatin: the first metal based anticancer drug. Bioorg Chem 88:102925. https://doi.org/10.1016/j.bioorg.2019.102925

Article  CAS  PubMed  Google Scholar 

Jiang S, Zou J, Dong J, Shi H, Chen J, Li Y, Duan X, Li W (2023) Lower SLC7A2 expression is associated with enhanced multidrug resistance, less immune infiltrates and worse prognosis of NSCLC. Cell Commun Signal 21:9. https://doi.org/10.1186/s12964-022-01023-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kryczka J, Kryczka J, Czarnecka-Chrebelska KH, Brzezianska-Lasota E (2021) Molecular mechanisms of chemoresistance induced by cisplatin in NSCLC cancer therapy. Int J Mol Sci 22. https://doi.org/10.3390/ijms22168885

Kun-Peng Z, Xiao-Long M, Chun-Lin Z (2017) LncRNA FENDRR sensitizes doxorubicin-resistance of osteosarcoma cells through down-regulating ABCB1 and ABCC1. Oncotarget 8:71881–71893. https://doi.org/10.18632/oncotarget.17985

Article  PubMed  PubMed Central  Google Scholar 

Li H, Chen YK, Wan Q, Shi AQ, Wang M, He P, Tang LX (2021) Long Non-coding RNA LINC00847 Induced by E2F1 accelerates non-small cell lung cancer progression through targeting miR-147a/IFITM1 Axis. Front Med (lausanne) 8:663558. https://doi.org/10.3389/fmed.2021.663558

Article  PubMed  Google Scholar 

Liang Y, Song J, He D, Xia Y, Wu Y, Yin X, Liu J (2019) Systematic analysis of survival-associated alternative splicing signatures uncovers prognostic predictors for head and neck cancer. J Cell Physiol 234:15836–15846. https://doi.org/10.1002/jcp.28241

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin X, Han T, Xia Q, Cui J, Zhuo M, Liang Y, Su W, Wang L, Wang L, Liu Z, Xiao X (2021) CHPF promotes gastric cancer tumorigenesis through the activation of E2F1. Cell Death Dis 12:876. https://doi.org/10.1038/s41419-021-04148-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Z, Pu Y, Bao Y, He S (2021) Investigation of potential molecular biomarkers for diagnosis and prognosis of AFP-negative HCC. Int J Gen Med 14:4369–4380. https://doi.org/10.2147/IJGM.S323868

Article  PubMed  PubMed Central  Google Scholar 

Lu G, Li Y, Ma Y, Lu J, Chen Y, Jiang Q, Qin Q, Zhao L, Huang Q, Luo Z, Huang S, Wei Z (2018) Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis. J Exp Clin Cancer Res 37:289. https://doi.org/10.1186/s13046-018-0945-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lugones Y, Loren P, Salazar LA (2022) Cisplatin resistance: genetic and epigenetic factors involved. Biomolecules 12. https://doi.org/10.3390/biom12101365

Lv X, Lian Y, Liu Z, Xiao J, Zhang D, Yin X (2021) Exosomal long non-coding RNA LINC00662 promotes non-small cell lung cancer progression by miR-320d/E2F1 axis. Aging (Albany NY) 13:6010–6024. https://doi.org/10.18632/aging.202522

Article  CAS  PubMed  Google Scholar 

Miller M, Hanna N (2021) Advances in systemic therapy for non-small cell lung cancer. BMJ 375:n2363. https://doi.org/10.1136/bmj.n2363

Article  PubMed  Google Scholar 

Shan KZ, Yang SF, Deng YJ, Yue PY, Du ZQ (2022) E2F1-induced long non-coding RNA MCF2L-AS1 modulates Cyclin D1 mRNA stability through ELAVL1 to induce Gefitinib resistance in non-small cell lung cancer. Acta Biochim Pol 69:795–804. https://doi.org/10.18388/abp.2020_6118

Article  CAS  PubMed  Google Scholar 

Sun R, Wang R, Chang S, Li K, Sun R, Wang M, Li Z (2019) Long non-coding RNA in drug resistance of non-small cell lung cancer: a mini review. Front Pharmacol 10:1457. https://doi.org/10.3389/fphar.2019.01457

Article  CAS  PubMed  PubMed Central  Google Scholar 

Suster DI, Mino-Kenudson M (2020) Molecular pathology of primary non-small cell lung cancer. Arch Med Res 51:784–798. https://doi.org/10.1016/j.arcmed.2020.08.004

Article  CAS  PubMed  Google Scholar 

Tan D, Li G, Zhang P, Peng C, He B (2022) LncRNA SNHG12 in extracellular vesicles derived from carcinoma-associated fibroblasts promotes cisplatin resistance in non-small cell lung cancer cells. Bioengineered 13:1838–1857. https://doi.org/10.1080/21655979.2021.2018099

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang A, Wang J (2020) E2F1-induced overexpression of long noncoding RNA SBF2-AS1 promotes non-small-cell lung cancer metastasis through regulating miR-362-3p/GRB2 Axis. DNA Cell Biol 39:1290–1298. https://doi.org/10.1089/dna.2020.5426

Article  CAS  PubMed  Google Scholar 

Wang L, Ma L, Xu F, Zhai W, Dong S, Yin L, Liu J, Yu Z (2018) Role of long non-coding RNA in drug resistance in non-small cell lung cancer. Thorac Cancer 9:761–768. https://doi.org/10.1111/1759-7714.12652

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang L, Shang X, Feng Q (2019) LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis. Cancer Biol Ther 20:261–271. https://doi.org/10.1080/15384047.2018.1529091

Article  CAS  PubMed  Google Scholar 

Wang Y, Zhang L, Wei N, Sun Y, Pan W, Chen Y (2020) Silencing LINC00482 inhibits tumor-associated inflammation and angiogenesis through down-regulation of MMP-15 via FOXA1 in bladder cancer. Aging (Albany NY) 13:2264–2278. https://doi.org/10.18632/aging.202247

Article  PubMed  Google Scholar 

Wang X, Chen Y, Dong K, Ma Y, Jin Q, Yin S, Zhu X, Wang S (2021) Effects of FER1L4-miR-106a-5p/miR-372-5p-E2F1 regulatory axis on drug resistance in liver cancer chemotherapy. Mol Ther Nucleic Acids 24:449–461. https://doi.org/10.1016/j.omtn.2021.02.006

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang W, Wang J, Liu S, Ren Y, Wang J, Liu S, Cui W, Jia L, Tang X, Yang J, Wu C, Wang L (2022) An EHMT2/NFYA-ALDH2 signaling axis modulates the RAF pathway to regulate paclitaxel resistance in lung cancer. Mol Cancer 21:106. https://doi.org/10.1186/s12943-022-01579-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xie H, Yao J, Wang Y, Ni B (2022) Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis. Drug Deliv 29:1257–1271. https://doi.org/10.1080/10717544.2022.2057617

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu Z, Lie RT, Wilcox AJ, Saugstad OD, Taylor JA (2019) A comparison of DNA methylation in newborn blood samples from infants with and without orofacial clefts. Clin Epigenetics 11:40. https://doi.org/10.1186/s13148-019-0638-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu R, Luo X, Ye X, Li H, Liu H, Du Q, Zhai Q (2021) SIRT1/PGC-1alpha/PPAR-gamma correlate with hypoxia-induced chemoresistance in non-small cell lung cancer. Front Oncol 11:682762. https://doi.org/10.3389/fonc.2021.682762

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang Y, Zhang P, Zhao Y, Yang J, Jiang G, Fan J (2016) Decreased MicroRNA-26a expression causes cisplatin resistance in human non-small cell lung cancer. Cancer Biol Ther 17:515–525. https://doi.org/10.1080/15384047.2015.1095405

Article  CAS  PubMed  Google Scholar 

Yang F, Zhao J, Luo X, Li T, Wang Z, Wei Q, Lu H, Meng Y, Cai K, Lu L, Lu Y, Chen L, Sooranna SR, Luo L, Song J, Meng L (2021) Transcriptome profiling reveals B-lineage cells contribute to the poor prognosis and metastasis of clear cell renal cell carcinoma. Front Oncol 11:731896. https://doi.org/10.3389/fonc.2021.731896

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zeng Z, Zhao G, Zhu H, Nie L, He L, Liu J, Li R, Xiao S, Hua G (2020) LncRNA FOXD3-AS1 promoted chemo-resistance of NSCLC cells via directly acting on miR-127-3p/MDM2 axis. Cancer Cell Int 20:350.